Search - tctmd.com

Displaying 381 - 400 of 1526

Sort: Relevancy | Date

Presentation Scripps 2016

The “Forgotten Valve”: Current and Emerging Options for Catheter Based Treatment of Tricuspid Regurgitation

Presenter: Rebecca T. Hahn

February 03, 2016

Presentation Scripps 2016

PVL Closure: Keys to Success

Presenter: Paul Sorajja

February 03, 2016

Presentation Scripps 2016

Intraprocedural TEE Guidance of Transcatheter Mitral Valve Repair

Presenter: William J. Stewart

February 03, 2016

Presentation Scripps 2016

Current Dataset for Transcatheter Mitral Repair and Its Impact on Patient Selection

Presenter: Jason H. Rogers

February 03, 2016

Presentation Scripps 2016

New Transcatheter Therapies: What Is Next On The Horizon?

Presenter: Susheel K. Kodali

February 02, 2016

Presentation Scripps 2016

Complex Case Studies: Everything but the Kitchen Sink

Presenter: Patricia A. Keegan

February 02, 2016

News Opinion Fellow Talk

Test Your Knowledge: 10 Essential Questions on the Evolution of Interventional Cardiology

Sarah Elsayed, MD

January 25, 2016

News Daily News

La Intervención Invasiva Precoz es Mejor que la Demorada en el Manejo de NSTE¬MI

Michael O'Riordan

January 20, 2016

News Daily News

Early Invasive Intervention Trumps Delayed Approach in NSTEMI Patients

Michael O'Riordan

January 20, 2016

News Industry News

Neovasc Receives FDA Approval to add 40mm Valve Size to the TIARA-I Clinical Trial

January 10, 2016

News Daily News

Muchos Supervivientes de Cáncer Infantil Presentan Patologías Cardíacas Silentes

Yael L. Maxwell

January 06, 2016

News Daily News

Many Childhood Cancer Survivors Have Silent Cardiac Conditions

Yael L. Maxwell

January 06, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

Presentation

Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation (MR):5-Year results of EVEREST II

Presenter: Ted Feldman

December 21, 2015

News Daily News

Percutaneous Mitral Repair Looks Durable, Safe, in 5-Year Final Results from EVEREST II

L.A. McKeown

December 21, 2015

News Daily News

La Reparación Mitral Percutánea parece Duradera y Segura en los Resultados a 5 Años del EVEREST II

L.A. McKeown

December 21, 2015

News Daily News

EVEREST II 5 年的最终结果显示经皮二尖瓣修补似乎持久、安全

L.A. McKeown

December 21, 2015

News Industry News

BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology

December 13, 2015

News Daily News

La 1ª Reparación Transcatéter en Humanos de la Válvula Tricúspide es Viable pero Plantea Interrogantes

Michael O'Riordan

December 06, 2015

News Daily News

First-In-Human Transcatheter Tricuspid Repair Feasible But Questions Remain

Michael O'Riordan

December 06, 2015

Advertisement

The “Forgotten Valve”: Current and Emerging Options for Catheter Based Treatment of Tricuspid Regurgitation

PVL Closure: Keys to Success

Intraprocedural TEE Guidance of Transcatheter Mitral Valve Repair

Current Dataset for Transcatheter Mitral Repair and Its Impact on Patient Selection

New Transcatheter Therapies: What Is Next On The Horizon?

Complex Case Studies: Everything but the Kitchen Sink

Test Your Knowledge: 10 Essential Questions on the Evolution of Interventional Cardiology

La Intervención Invasiva Precoz es Mejor que la Demorada en el Manejo de NSTE¬MI

Early Invasive Intervention Trumps Delayed Approach in NSTEMI Patients

Neovasc Receives FDA Approval to add 40mm Valve Size to the TIARA-I Clinical Trial

Muchos Supervivientes de Cáncer Infantil Presentan Patologías Cardíacas Silentes

Many Childhood Cancer Survivors Have Silent Cardiac Conditions

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation (MR):5-Year results of EVEREST II

Percutaneous Mitral Repair Looks Durable, Safe, in 5-Year Final Results from EVEREST II

La Reparación Mitral Percutánea parece Duradera y Segura en los Resultados a 5 Años del EVEREST II

EVEREST II 5 年的最终结果显示经皮二尖瓣修补似乎持久、安全

BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology

La 1ª Reparación Transcatéter en Humanos de la Válvula Tricúspide es Viable pero Plantea Interrogantes

First-In-Human Transcatheter Tricuspid Repair Feasible But Questions Remain

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content